| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 98 |
| 1 | METHOTREXATE SODIUM | 89 |
| 2 | PREDNISONE | 87 |
| 3 | METHOTREXATE | 81 |
| 4 | ETANERCEPT | 63 |
| 5 | METHYLPREDNISOLONE | 58 |
| 6 | ADALIMUMAB-AATY | 54 |
| 7 | ADALIMUMAB-ADAZ | 52 |
| 8 | ADALIMUMAB-FKJP | 52 |
| 9 | INFLIXIMAB | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DESONIDE 0.05% | 1 | 0.1111 |
| 1 | ADALIMUMAB-AQVH | 1 | 0.0101 |
| 2 | LINCOMYCIN HYDROCHLORIDE | 2 | 0.0068 |
| 3 | ALDESLEUKIN | 3 | 0.0024 |
| 4 | CHROMIC CHLORIDE | 2 | 0.0023 |
| 5 | ETHIODIZED OIL | 3 | 0.0023 |
| 6 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 7 | ETHACRYNIC ACID | 1 | 0.0018 |
| 8 | POTASSIUM BICARBONATE | 1 | 0.0014 |
| 9 | ADALIMUMAB-FKJP | 52 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 153 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 133 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 81 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 4 | Purine Antimetabolite [EPC] | 37 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 33 |
| 6 | Vitamin C [EPC] | 30 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| 8 | Vitamin B12 [EPC] | 28 |
| 9 | Vitamin D [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 2 | Alkaloid [EPC] | 15 | 0.0006 |
| 3 | Sulfone [EPC] | 5 | 0.0005 |
| 4 | Purine Antimetabolite [EPC] | 37 | 0.0004 |
| 5 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 6 | Aminosalicylate [EPC] | 25 | 0.0002 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 33 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 9 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |